Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Howton Insider Profile
4 Followers
David Howton, EVP & GC at Sarepta Therapeutics, holds 24.79K shares in Solid Biosciences (Ticker: SLDB), holds 31.87K shares in Sarepta Therapeutics (Ticker: SRPT), holds 19.70K shares in Vertex Pharmaceuticals (Ticker: VRTX).
David Howton has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Howton holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David Howton
David Howton's Trading History
Sarepta Therapeutics
Jun 22, 2020
EVP & GC
Uninformative Buy
2.71M
$3.46M
Solid Biosciences
Feb 18, 2025
COO
Uninformative Buy
35.96K
$148.73K
Vertex Pharmaceuticals
Feb 06, 2012
SVP & CLO
Uninformative Buy
101.66
$9.46M
List of latest transactions for each holding click on a transaction to see David Howton's performance on stock
You May Also Like
David Howton insider profile FAQ
What is the percentage of profitable transactions made by David Howton?
The percentage of profitable transactions made by David Howton is ―.
What is the average return per transaction made by David Howton?
The average return per transaction made by David Howton is ―.
What stocks does David Howton hold?
David Howton holds: SRPT, SLDB, VRTX stocks.
What was David Howton’s latest transaction?
David Howton latest transaction was an Uninformative Buy of $35.96K.
What was David Howton's most profitable transaction?
David Howton’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David Howton's role in Sarepta Therapeutics?
David Howton's role in Sarepta Therapeutics is EVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.